Rodrigo Taboada

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2024
The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors.

Rodrigo G Taboada, Angelo B Brito, Ana Luiza Silva

|May 31, 2022
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes.

Rodrigo G Taboada, Rachel P Riechelmann, Carine Mauro

|Feb 17, 2022
Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms.

Rodrigo Taboada, Laura Claro, Tiago Felismino

|Aug 27, 2021
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Melissa Frizziero, Alice Durand, Rodrigo G Taboada

Pageof 1